Acridine-9-carbaldehyde

Catalog No.: 
ACHRGX134
CAS No.: 
885-23-4
Molecular Formula: 
C14H9NO
Molecular Weight: 
207.23
Acridine-9-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$53.00In stockInquiry
250mg95%$82.00In stockIn stock
1g95%$215.00In stockIn stock
5g95%$722.00In stockIn stock
25g95%$2657.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAcridine-9-carbaldehyde
IUPAC Nameacridine-9-carbaldehyde
MDL No.MFCD00616515
Molecular FormulaC14H9NO
Molecular Weight207.23
SMILESO=CC1=C(C=CC=C2)C2=NC3=CC=CC=C31
InChI KeyISOCABSXIKQOOV-UHFFFAOYSA-N
SynonymFT-0709258 | DTXSID50237081 | Acridine-9-carbaldehyde | UNII-5XN5ZGH695 | 9-Acridinecarboxaldehyde(8ci)(9ci) | 9-Formylacridine | Q27456991 | 9-Acridinecarboxaldehyde | Acridine-9-carboxaldehyde, 97% | AKOS015904343 | 9-ACRIDINOYL | 9-Acridinealdehyde | 9
CAS No.885-23-4
PubChem CID98663

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACHRGX134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRIVO169 route compound structure diagram
    ACRIVO169611-64-3In Stock
  2. Then
  3. ACHRGX134 route product structure diagram
    ACHRGX134885-23-4In Stock
Inquiry

2. ACHRGX134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHRGX134 route product structure diagram
    ACHRGX134885-23-4In Stock
Inquiry

3. ACHRGX134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHRGX134 route product structure diagram
    ACHRGX134885-23-4In Stock
Inquiry

Comments (0)